Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation | Zendy

Alexander Sedaghat | Zendy; Nils Neumann | Zendy; Nadjib Schahab | Zendy; JanMalte Sinning | Zendy; Christoph Hammerstingl | Zendy; Simon Pingel | Zendy; Christian Schaefer | Zendy; Fritz Mellert | Zendy; Wolfgang Schiller | Zendy; Armin Welz | Zendy; Eberhard Grube | Zendy; Georg Nickenig | Zendy; Nikos Werner | Zendy

Open Access

Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation

Author(s) -

Alexander Sedaghat,

Nils Neumann,

Nadjib Schahab,

JanMalte Sinning,

Christoph Hammerstingl,

Simon Pingel,

Christian Schaefer,

Fritz Mellert,

Wolfgang Schiller,

Armin Welz,

Eberhard Grube,

Georg Nickenig,

Nikos Werner

Publication year - 2016

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.116.003834

Subject(s) - medicine , stent , surgery , interquartile range , stenosis , cohort , asymptomatic , complication , radiology

Access-site and access-related vascular injury (ASARVI) is still a major limiting factor in transcatheter aortic valve implantation and affects the outcome of patients. Management strategies for ASARVI include manual compression, stent grafts, and vascular surgery. We hypothesized that the standard use of a self-expanding stent graft for the management of ASARVI is feasible and safe.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research